⌘K

Home/Filings/4/0001415889-24-019024

4//SEC Filing

Anderson Cynthia Lynn 4

Accession 0001415889-24-019024

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:08 PM ET

Size

5.0 KB

Accession

0001415889-24-019024

Insider Transaction Report

Form 4

Period: 2024-06-28

Vistagen Therapeutics, Inc.VTGN

Anderson Cynthia Lynn

CHIEF FINANCIAL OFFICER

Transactions

Award
Common Stock
2024-06-28$2.96/sh+3,592$10,625→ 3,592 total

Footnotes (1)

[F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.

Documents

1 file

4
form4-07022024_100748.xmlPrimary

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001989905

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 6:08 PM ET
Size: 5.0 KB

View on SEC.gov